ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1838

The Burden of Dysautonomia in Patients Suffering from Pathologies Associated with Generalized Joint Hypermobility

Alizée Perrein1, Fabien Pontille1, Paul Decker2, david Attali3, Thomas Moulinet4 and Roland Jaussaud5, 1Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre-les-Nancy, France, 2Nancy hospital, France, Nancy, France, 3Université Paris Cité, Laboratoire Psychopathologie et Processus de Santé, Boulogne-Billancourt, France, 4Department of Internal Medicine, Centre hospitalier universitaire de Nancy, Nancy, France, 5Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre Les Nancy, France

Meeting: ACR Convergence 2023

Keywords: Anxiety, depression, Disability, Ehlers-Danlos, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1827–1839) Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Hypermobility spectrum disorders (HSD) and hypermobile Ehlers Danlos syndrome (hEDS) are among the conditions associated with generalized joint hypermobility (GJH). Alongside myofascial and skeletal pain manifestations, other polymorphic co-morbid manifestations, often multiple, are linked to an autonomic dysregulation syndrome. The aim of this study was to characterize the impact of dysautonomia in patients suffering from joint hypermobility syndrome (HSD/hEDS).

Methods: Incident patients were recruited from consultations at the Center of Competence for Rare Diseases of Non-Vascular EDS. Inclusion criteria were GJH and clinical criteria for hEDS or HSD. Scores on the following questionnaires were collected : SCOPA-AUT (dysautonomia), Nijmegen (hyperventilation), HAD (anxiety, depression), Tampa (kinesiophobia), PSQI (sleep), Gastro-Intestinal Quality of Life Index (GIQLI), Pichot (fatigue), VAS physical pain and VAS psychological pain, VAS quality of life. A comparison of the 2 hEDS and HSD groups was carried out, followed by a principal component analysis (PCA). The search of homogeneous groups of patients was carried out using hierachical cluster analysis.

Results: 36 patients were included (18 hEDS, 18 HSD) with a significantly higher level of anxiety-depression in the hEDS group (25.33 vs 18.39, p = 0.017). The Nijmegen score was higher in the hEDS group (46.91 vs 38.94, p = 0.016). The mean SCOPA-AUT score was 37.08 ± 9.86 and did not differ significantly between the 2 groups; there was no statistically significant difference between the 2 groups for the other parameters studied. The level of dysautonomia was correlated with younger age, high Nijmegen score, kinesiophobia, fatigue, sleep disturbance, marked anxiety-depressive syndrome and poor GI QoL. PCA revealed a strong correlation between the level of dysautonomia and GI QoL. Two homogeneous groups of patients were identified : one of which (n = 23)  was characterized by very high impairment of GI QoL and a high level of dysautonomia.

Conclusion: Our study illustrates the importance of dysautonomia as a major comorbidity in HSD/hEDS. Dysfunctional breathing seems almost constant, and dysautonomia is associated with a major impairment of GI QoL. An anxiety or depressive disorder is very common in these situations, and supports the recently put forward hypothesis of a neuroconnective phenotype. The polyvagal theory provides important physiological clues for understanding these pathologies and for their therapeutic management.


Disclosures: A. Perrein: None; F. Pontille: None; P. Decker: None; d. Attali: None; T. Moulinet: None; R. Jaussaud: None.

To cite this abstract in AMA style:

Perrein A, Pontille F, Decker P, Attali d, Moulinet T, Jaussaud R. The Burden of Dysautonomia in Patients Suffering from Pathologies Associated with Generalized Joint Hypermobility [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-burden-of-dysautonomia-in-patients-suffering-from-pathologies-associated-with-generalized-joint-hypermobility/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-burden-of-dysautonomia-in-patients-suffering-from-pathologies-associated-with-generalized-joint-hypermobility/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology